We are live on
!
Find out more
SCV
Sands Capital Ventures Portfolio holdings
AUM
$614M
1-Year Est. Return
19.92%
This Fund
S&P 500
This Quarter
Est. Return
+23.4%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$356M
AUM Growth
+$57.2M
(+19%)
Cap. Flow
-$3.03M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
98.23%
Holding
21
New
1
Increased
2
Reduced
4
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIOA
BioAge Labs
BIOA
|
+$21.8M |
| 2 |
Datadog
DDOG
|
+$45.7K |
| 3 |
DoorDash
DASH
|
+$30K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$24.6M |
| 2 |
Absci
ABSI
|
+$178K |
| 3 |
Samsara
IOT
|
+$43.2K |
| 4 |
Klaviyo
KVYO
|
+$26K |
| 5 |
Toast
TOST
|
+$12.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.76% |
| 2 | Financials | 21.1% |
| 3 | Healthcare | 19.07% |
| 4 | Consumer Discretionary | 17.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Klaviyo
KVYO
$5.26B
| $124M | 34.96% |
3,515,325
-896
| -0% | -$26K |
|
|
2
Nu Holdings
NU
$73.6B
| $75.1M | 21.1% |
5,498,802
-1,829,492
| -25% | -$24.6M |
|
|
3
DoorDash
DASH
$94B
| $60.4M | 16.98% |
423,338
+247
| +0.1% | +$30K |
|
|
BIOA
4
BioAge Labs
BIOA
$487M
| $22.6M | 6.35% |
+1,086,353
| New | +$21.8M |
|
5
Acrivon Therapeutics
ACRV
$83.6M
| $14.9M | 4.18% |
2,122,605
| – | – |
|
6
UiPath
PATH
$8.3B
| $14.8M | 4.16% |
1,155,246
| – | – |
|
7
Snowflake
SNOW
$114B
| $12.4M | 3.5% |
108,304
| – | – |
|
8
10x Genomics
TXG
$7.31B
| $10.9M | 3.06% |
481,770
| – | – |
|
9
Acumen Pharmaceuticals
ABOS
$193M
| $8.47M | 2.38% |
3,417,075
| – | – |
|
10
Tarsus Pharmaceuticals
TARS
$3.04B
| $5.59M | 1.57% |
170,000
| – | – |
|
11
Candel Therapeutics
CADL
$897M
| $2.81M | 0.79% |
405,837
| – | – |
|
12
Taysha Gene Therapies
TSHA
$1.94B
| $1.46M | 0.41% |
724,873
| – | – |
|
13
908 Devices
MASS
$414M
| $823K | 0.23% |
237,258
| – | – |
|
|
SPRB
14
Spruce Biosciences
SPRB
$151M
| $370K | 0.1% |
10,493
| – | – |
|
15
Coupang
CPNG
$29B
| $293K | 0.08% |
11,931
| – | – |
|
|
16
Datadog
DDOG
$91.7B
| $162K | 0.05% |
1,406
+391
| +39% | +$45.7K |
|
|
17
Samsara
IOT
$23.2B
| $153K | 0.04% |
3,172
-1,067
| -25% | -$43.2K |
|
|
18
Toast
TOST
$20.1B
| $126K | 0.04% |
4,453
-492
| -10% | -$12.5K |
|
19
CrowdStrike
CRWD
$221B
| $62K | 0.02% |
884
| – | – |
|
20
GitLab
GTLB
$7.2B
| $33.9K | 0.01% |
658
| – | – |
|
|
21
Absci
ABSI
$1.58B
| – | – |
-57,804
| Closed | -$178K |
|
Similar funds
T2I
VAG
MKA
CSIA
ATFA
AA
FWM
FSA
Sands Capital Ventures's Q3 2024 Portfolio in Review
As of Q3 2024, Sands Capital Ventures held 21 positions worth $356M, up 19% from $299M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Sands Capital Ventures's Q3 2024 filing shows 1 new, 2 increased, 4 reduced and 1 closed positions. Its largest new stake was BioAge Labs: 1,086,353 shares worth $22.6M. The largest sale was Nu Holdings, an estimated $24.6M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Financials and Healthcare.
- Sands Capital Ventures's largest Q3 2024 buy was BioAge Labs: 1,086,353 shares worth $22.6M.
- Sands Capital Ventures added most to Datadog in Q3 2024, an estimated $45.7K increase.
- Sands Capital Ventures's biggest Q3 2024 reduction was Nu Holdings, cutting an estimated $24.6M.
- Sands Capital Ventures fully exited Absci in Q3 2024, selling an estimated $178K.
- Sands Capital Ventures's ten largest holdings make up 98% of its $356M portfolio in Q3 2024.
- Sands Capital Ventures opened 1 new position and closed 1 in Q3 2024.
- Sands Capital Ventures's portfolio value rose 19% quarter-over-quarter to $356M.
Based on Sands Capital Ventures's 13F filing for Q3 2024, filed 13 Nov 2024.